“Long-Term Efficacy of Abrocitinib in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE EXTEND” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s329. doi:10.25251/skin.8.supp.329.